Philanthropic Support from Dr. Marie and Mr. Vijay Goradia Enables Research Collaboration to Study 11h in Alzheimer’s Disease

Fannin-founded Goldenrod Therapeutics and UT Health San Antonio’s Glenn Biggs Institute are evaluating the investigational PDE4 inhibitor in preclinical models of Alzheimer’s disease

← Previous
Next →
  • HEALTH / LIFESTYLE
  • ARTICLES OF INTEREST
  • ABOUT
    • EDITORIAL
    • SUBMIT PRESS RELEASES
  • ADVERTISE
  • CONTACT
  • PRIVACY
    • COOKIE POLICY
  • HEALTH / LIFESTYLE
  • ARTICLES OF INTEREST
  • ABOUT
    • EDITORIAL
    • SUBMIT PRESS RELEASES
  • ADVERTISE
  • CONTACT
  • PRIVACY
    • COOKIE POLICY

© 2026 All rights Reserved. Medical Device News Magazine, is a Division of PTM Healthcare Marketing, Inc.